MLV & Co. Initiates Evoke Pharma At Hold

Analysts at MLV & Co. initiated coverage on Evoke Pharma

with a Buy rating. The target price for Evoke Pharma is set to $12.50. Evoke Pharma shares have dropped 31.96% over the past 52 weeks, while the S&P 500 index has gained 14.72% in the same period. Evoke Pharma's shares rose 0.15% to close at $6.62 yesterday.